Reza Jafari, V.M.D., Ph.D.

Assistant Professor of Medical Immunology

Solid Tumor Research Center (STRC)

Cellular and Molecular Medicine Institute

Urmia University of Medical Sciences


I received a Ph.D. in Medical Immunology from Mashhad University of Medical Sciences (MUMS) where I was trained at Ghaem Hospital, Department of Clinical Immunology & Allergy. 

My Ph.D. thesis was designed about targeted co-delivery of the chemotherapeutic drug and IGF-1R siRNA by chitosan nanoparticles for improving immunotherapy by an  anti-HER2 monoclonal antibody I also did some research at Immunology Research Center (IRC) of Tabriz University of Medical Sciences (TBZMED) as a Visiting Ph.D. Scholar.

I have joined to Solid Tumor Research Center (STRC) of Urmia University of Medical Sciences (UMSU) from August 2019, as an Assistant Professor of Medical Immunology & Immunotherapy.

After the incidence of SARS-CoV-2, we set up the plasma therapy for the management of severe COVID-19 patients at UMSU. 

My current research interests focus on three topics: Cancer immune-based gene silencing in vitro and in vivo, Immunology and immunotherapy of COVID-19, and Human retrovirology.


We have international collaboration with:


1. Professor Fatah Kashanchi, Director of the Laboratory of Molecular Virology at Geroge Mason University, Manassas, USA.


2. Professor Reza Nassiri, Department of Pharmacology & Toxicology, Michigan State University, Michigan, USA.


3. Professor Alireza Ranjbar, Director of Institute of Interventional Allergology and Immunology, Bonn, Germany